HepaPredict AB
559057-7044ActiveSpecialized CRO using 3D liver spheroids for drug toxicity prediction.
Overview
- 1–4
- Employees
- 1–2.5M SEK
- Revenue
- 2016
- Founded
Key Decision Makers
Volker Lauschke
Co-founder and CEO
Magnus Ingelman-Sundberg
Co-founder and Chairman of the Board
Bo Qwarnström
Member of the Board
Sabine U. Vorrink
Chief Operating Officer (COO)
Description
HepaPredict AB is a specialized Contract Research Organization (CRO) founded in 2016 as a spin-off from Karolinska Institutet. The company focuses intensely on drug metabolism, toxicity assessment, and drug development services specifically related to liver diseases. Their primary offering revolves...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Teknisk provning och analys
- Legal Form
- Aktiebolag
- VAT Number
- SE559057704401
Decision Makers
4 contacts in FunnelfeedrVolker Lauschke
Co-founder and CEO
Magnus Ingelman-Sundberg
Co-founder and Chairman of the Board
Bo Qwarnström
Member of the Board
Sabine U. Vorrink
Chief Operating Officer (COO)
Similar Companies
19 similar companies in FunnelfeedrLegado Bioresearch AB
2 employeesExpert CRO providing specialized in vivo research and consulting services.
Lucero AB
7 employeesDeveloping thaw-and-dose spheroids for faster preclinical drug discovery.
Cell2Bio AB
2 employeesPlatform enabling high-performance 3D cell spheroid growth for research.
True Dose AB
1–4 employeesEmpowering precision dosing via innovative at-home blood sampling technology.
Medetect AB
5 employeesCutting-edge histology and image analysis solutions for drug discovery.
HepaPredict AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo